文献速递眼底病与葡萄膜炎白内障与屈光手术

万古霉素相关出血性闭塞性视网膜血管炎:36只眼的临床特征

Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes.
PubMed 文献 · Ophthalmology · 2017-01-19

美国白内障与屈光手术学会(ASCRS)和美国视网膜专家学会(ASRS)联合工作组通过在线登记和文献检索,回顾性分析23例患者36只眼的万古霉素相关出血性闭塞性视网膜血管炎(HORV)。所有眼均接受眼内万古霉素,典型表现为术后第1天检查无异常、迟发性无痛性视力丧失、轻度前房和玻璃体炎症、缺血区扇形视网膜出血;视力预后差,22/36眼(61%)视力≤20/200,8/36眼(22%)无光感,20/36眼(56%)发生新生血管性青光眼。

要点

  • HORV典型表现:术后第1天未散瞳检查无异常,迟发性无痛性视力丧失,轻度前房和玻璃体炎症,缺血区扇形视网膜出血。
  • 全部36只眼均接受眼内万古霉素:33/36经前房推注,1/36经玻璃体腔注射,2/36经灌洗瓶。
  • 视力预后差:22/36眼(61%)视力≤20/200,8/36眼(22%)无光感;20/36眼(56%)发生新生血管性青光眼。

核心结论

  • HORV是白内障手术或眼内注射后可能发生的罕见、潜在破坏性疾病。
  • 本系列所有病例均与眼内万古霉素相关,病程和表现提示HORV由对万古霉素的迟发型超敏反应引起。
  • 早期皮质类固醇治疗可能有益;随后抗血管内皮生长因子注射和全视网膜光凝对预防新生血管性青光眼这一常见并发症很重要。
  • 若怀疑HORV,推荐避免再次玻璃体腔注射万古霉素。

研究设计与样本

  • 回顾性病例系列。
  • ASCRS与ASRS成立联合工作组,在两学会网站建立在线登记,向会员发送邮件调查疑似HORV病例,并进行文献检索。
  • 共纳入23例患者36只眼。

主要发现

  • HORV特征性表现包括术后第1天未散瞳检查无异常、迟发性无痛性视力丧失、轻度前房和玻璃体炎症、缺血区扇形视网膜出血,以及好发于小静脉和周边部。
  • 全部36只眼均接受眼内万古霉素:33/36经前房推注,1/36经玻璃体腔注射,2/36经灌洗瓶。
  • 患者于手术或玻璃体腔注射后1至21天出现HORV。
  • 22/36眼(61%)视力≤20/200,8/36眼(22%)无光感;20/36眼(56%)发生新生血管性青光眼。
  • 7只眼术后接受额外玻璃体腔万古霉素,其中5/7只眼最近一次检查时无光感;3只眼接受玻璃体腔皮质类固醇,最终视力分别为20/40、20/70和手动。

关键数值与推荐

  • 基于预先确定的诊断标准,36只眼(23例患者)诊断为HORV。
  • 若怀疑HORV,推荐避免再次玻璃体腔注射万古霉素。

临床怎么用

  • 作者认为早期皮质类固醇治疗可能有益。
  • 作者认为随后抗血管内皮生长因子注射和全视网膜光凝对预防新生血管性青光眼很重要。
  • 若怀疑HORV,推荐避免再次玻璃体腔注射万古霉素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To expand understanding of presentation, diagnosis, and outcomes of hemorrhagic occlusive retinal vasculitis (HORV). DESIGN: Retrospective case series. PARTICIPANTS: Thirty-six eyes of 23 patients. METHODS: The American Society of Cataract and Refractive Surgery (ASCRS) and the American Society of Retina Specialists (ASRS) formed a joint task force to define clinical characteristics of HORV and to study its prevalence, cause, treatment, and outcomes. An online registry was established on both societies' web sites. Surveys were e-mailed to members of both societies soliciting cases of suspected HORV. A literature search was performed to uncover additional cases. MAIN OUTCOME MEASURES: Historical data including intraoperative characteristics, images, treatment regimens, and visual and anatomic outcomes. RESULTS: Characteristic findings of HORV included unremarkable postoperative day 1 undilated examination, delayed-onset painless vision loss, mild anterior chamber and vitreous inflammation, sectoral retinal hemorrhages in areas of ischemia, and predilection for venules and peripheral involvement. Based on predetermined diagnostic criteria, 36 eyes of 23 patients were diagnosed with HORV. All eyes received intraocular vancomycin via intracameral bolus (33/36), via intravitreal injection (1/36), or through the irrigation bottle (2/36). Patients sought treatment with HORV 1 to 21 days after surgery or intravitreal injection. Visual results usually were poor: 22 of 36 eyes (61%) had 20/200 or worse visual acuity and 8 of 36 eyes (22%) had no light perception (NLP). Neovascular glaucoma developed in 20 of 36 eyes (56%). Seven eyes received additional intravitreal vancomycin after surgery; 5 of these 7 eyes had NLP visual acuity at the most recent examination. Three eyes received intravitreal corticosteroids and had final visual acuities of 20/40, 20/70, and hand movements. CONCLUSIONS: Hemorrhagic occlusive retinal vasculitis is a rare, potentially devastating condition that can develop after cataract surgery or intraocular injection. All cases in this series were associated with intraocular vancomycin. Disease course and findings suggest that HORV is caused by a delayed hypersensitivity reaction to vancomycin. Early treatment with corticosteroids likely is beneficial. Subsequently, anti-vascular endothelial growth factor injections and panretinal photocoagulation are important to prevent neovascular glaucoma, a common complication. Avoidance of additional intravitreal vancomycin is recommended if HORV is suspected.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Witkin AJ, Chang DF, Jumper JM, et al. Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: Clinical Characteristics of 36 Eyes. Ophthalmology. 2017. PMID: 28110950. doi:10.1016/j.ophtha.2016.11.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。